![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BIOGENEX APPROVED TO SELL BREAST CANCER DIAGNOSTIC KIT
BIOGENEX APPROVED TO SELL BREAST CANCER DIAGNOSTIC KIT
BioGenex Laboratories has won approval from federal regulators to sell a diagnostic kit that would help doctors determine which breast cancer patients are eligible for treatment with the Genentech drug Herceptin.
East Bay Business Times (http://www.bizjournals.com/eastbay/stories/2005/01/17/daily12.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct